Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]

2003-02-01

Leukemia , Volume 17 - Issue 2 p. 468- 470

Additional Metadata
Persistent URL	doi.org/10.1038/sj.leu.2402749, hdl.handle.net/1765/53695
Journal	Leukemia
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Zwaan, M., Reinhardt, D., Jürgens, H., Huismans, D., Hählen, K., Smith, O. P., … Kaspers, G. (2003). Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]. Leukemia, 17(2), 468–470. doi:10.1038/sj.leu.2402749

Publication